Novotech Receives CRO Leadership Award for Exceeding Customer Expectations
Retrieved on:
星期四, 六月 23, 2022
Solution, Time, Industry, Industry Standard, Drug development, AHFS Drug Information Book, Technology, CEO, Cros, Research, Leadership, Ownership, Problem solving, Clinical trial, Acceleration, Investment, Lists of people executed in the United States, Workforce, IRS, ISR, DIA, Asia-Pacific, CRO, Benchmarking, Fine chemical, Pharmaceutical industry
CHICAGO, IL, June 23, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was awarded a prestigious Clinical Leader and Life Science Leader CRO Leadership Award for exceeding customer expectations, at Drug Information Association 2022 (DIA 2022).
Key Points:
- CHICAGO, IL, June 23, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was awarded a prestigious Clinical Leader and Life Science Leader CRO Leadership Award for exceeding customer expectations, at Drug Information Association 2022 (DIA 2022).
- Novotech CEO Dr. John Moller said the company was extremely pleased to receive this award for the second consecutive year.
- https://novotech-cro.com/contact
Clinical Leader and Life Science Leader working with Industry Standard Research (ISR), selected Novotech for the CRO Leadership Award. - According to the CRO Leadership Award research team: "The awards are based on customer feedback.